Florensocatib, an inhibitor of dipeptidyl peptidase-1, for the treatment of non-cystic fibrosis bronchiectasis: Rationale and Design of the FABLE Phase III trial

J D Chalmers, F C Ringshausen, P Iveli, T Arslan, N Baririan, S Biondaro, S Druelles, G Giorli, S Grant, B Guidoux, R Macchia, D MacLennan, F Zuccaro, L Labadini · Pneumologie · 2026 · Heft S 02 S 02 · S. e68